Portfolio 1
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 12, 2025 | AI-Driven Biotech Iambic Secures Over $100M for Drug Discovery | Iambic, a San Diego AI-driven biotech, secured over $100M in funding. This capital fuels its advanced AI drug discovery platform and expanding clinical pipeline. The company rapidly advances novel therapies, like IAM1363, showing strong ant... |
| Nov 10, 2025 | Iambic: $100 Million Raised To Advance AI-Discovered Therapeutics And Platform Technologies | Iambic, a clinical-stage life science and technology company headquartered in San Diego, announced that it has raised more than $100 million in an oversubscribed financing round. The round drew participation from a broad group of new and ex... |
| Apr 16, 2024 | Regeneron Ventures Launches with $500M to Accelerate Biotech Innovation | Regeneron Ventures, a Greenwich, Conn.-based biotech focused venture capital firm, announced its launch. Regeneron Pharmaceuticals is the fund’s exclusive limited partner and has committed $100m annually for five years. Read more on VCWire.... |
Reviews 0
FAQ about Regeneron Ventures
How many startups has Regeneron Ventures invested in?
Regeneron Ventures has 1 portfolio company on Parsers VC.
What has the press written about Regeneron Ventures?
Parsers VC has collected 4 articles mentioning Regeneron Ventures, among them “AI-Driven Biotech Iambic Secures Over $100M for Drug Discovery” (Nov 12, 2025) and “Iambic: $100 Million Raised To Advance AI-Discovered Therapeutics And Platform Technologies” (Nov 10, 2025).
Is Regeneron Ventures still active?
Yes, Regeneron Ventures is active; its latest activity on Parsers VC dates from Oct 30, 2026.